Reaction

Hypersensitivity Myocarditis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 120 reports · 3 co-occurring drugs

As of the last recalculation, Hypersensitivity Myocarditis appears in 120 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is FONDAPARINUX SODIUM (PRR 259.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Fondaparinux Sodium	11	259.4	259.8
Ticagrelor	22	146.3	146.4
Apalutamide	3	45.4	45.4

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.